Synthesis and biological evaluation of sialylmimetics as rotavirus inhibitors

Journal of Medicinal Chemistry

Volumn 44, Issue 20, 2001, Pages 3292-3301

  Fazli, A ^a   Bradley, S J ^a   Kiefel, M J ^a,b   Jolly, C ^c   Holmes, I H ^c   Von Itzstein, M ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLNEURAMINIC ACID; SIALIC ACID DERIVATIVE; THIOGLYCOSIDE; VIRUS VACCINE;

ARTICLE; DRUG SYNTHESIS; GASTROENTERITIS; ROTAVIRUS; VIRUS INFECTION; VIRUS INHIBITION;

ANIMALS; ANTIVIRAL AGENTS; CATTLE; CELL LINE; GLYCOSIDES; HUMANS; MOLECULAR MIMICRY; N-ACETYLNEURAMINIC ACID; NEUTRALIZATION TESTS; ROTAVIRUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0035959910     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0100887     Document Type: Article

References (56)

1. Rotaviruses and their replication
2. Rotavirus gene structure and function
3. Rotavirus contains integrin ligand sequences and a disintegrin-like domain implicated in virus entry into cells
4. Genetic mapping indicates that VP4 is the rotavirus cell attachment protein in vitro and in vivo
5. The VP5 domain of VP4 can mediate attachment of rotaviruses to cells
6. Viral determinants of rotavirus pathogenicity in pigs: Production of reassortments by asynchronous coinfection
7. Viral determinants of rotavirus pathogenicity in pigs: Evidence that the fourth gene of a porcine rotavirus confers diarrhea in the homologous host
8. Three-dimensional structure of the rotavirus haemagglutinin VP4 by cryo-electron microscopy and difference map analysis
9. Three-dimensional visualization of the rotavirus haemagglutinin structure
10. Characterisation of G serotype dependent nonantibody inhibitors of rotavirus in normal mouse serum
11. Interactions between the two surface proteins of rotavirus may alter the receptor-binding specificity of the virus
12. Rotavirus vaccines and vaccination potential
13. Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus
14. Preparation and characterization of antiserums to electrophoretically purified SA11 virus polypeptides
15. Entry of rotavirus is a multistep process
16. Liposome mediated transfection of intact viral particles reveals that plasma membrane determines permissivity of tissue culture cells to rotavirus
17. Comparison of human, simian, and bovine rotaviruses for requirement of sialic acid in hemagglutination and cell adsorption
18. Structure and function of a ganglioside receptor for porcine rotavirus
19. 1a on the cell surface is involved in the infection by human rotavirus KUN and MO strains
20. Characterisation of binding of simian rotavirus SA-11 to cultured epithelial cells
21. Binding to sialic acids is not an essential step for the entry of animal rotaviruses to epithelial cells in culture
22. Gangliosides as binding sites in SA-11 rotavirus infection of LLC-MK2 cells
23. Functional and structural analysis of the sialic acid-binding domain of rotaviruses
24. Human and most animal rotavirus strains do not require the presence of sialic acid on the cell surface for efficient infectivity
25. Cell surface ligands for rotavirus: Mouse intestinal glycolipids and synthetic carbohydrate analogues
26. Rotaviruses specifically bind to the neutral glycosphingolipid asialo-GM1
27. Rotaviruses preferentially bind O-linked sialylglycoconjugates and sialomucins
28. Identification of mutations in the rotavirus protein VP4 that alter sialic acid-dependent infection
29. Biochemical characterisation of rotavirus receptors in MA104 cells
30. Rotavirus infection of MA104 cells is inhibited by Ricinus lectin and separately expressed single binding domains
31. Glycosphingolipid binding specificities of rotavirus: Identification of a sialic acid-binding epitope
32. Role of human-milk lactadherin in protection against symptomatic rotavirus infection
33. Sialyloligosaccharides from egg yolk as an inhibitor of rotaviral infection
34. Synthesis of a novel sialic acid derivative (sialylphospholipid) as an antirotaviral agent
35. Synthesis and biological evaluation of N-acetylneuraminic acid-based rotavirus inhibitors
36. SA11 rotavirus is specifically inhibited by an acetylated sialic acid
37. Sialic acid glycoproteins inhibit in vitro and in vivo replication of rotaviruses
38. Synthesis of sialic acid analogues and their behaviour towards the enzymes of sialic acid metabolism and haemagglutinin X-31 of influenza A-virus
39. Sialic acid analogues as potential antimicrobial agents
40. Carbohydrate mimetics: A new strategy for tackling the problem of carbohydrate-mediated biological recognition
41. Synthesis of novel sialyl Lewis x glycomimetics as selectin antagonists
42. Design, synthesis and biological evaluation of aryl-substituted sialyl lewis x mimetics prepared via cross-metathesis of C-fucopeptides
43. Sialoside mimetics and conjugates as antiinflammatory agents and inhibitors of flu virus infections
44. Emerging roles of carbohydrates and glycomimetics in anticancer drug design
45. Second generation mimetics of ganglioside GM1 as artificial receptors for cholera toxin: Replacement of the sialic acid moiety
46. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: Design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity
47. Rational design of potent sialidase-based inhibitors of influenza virus replication
48. 4-β-D-glucopyranosiduronic acids as mimetics of 2,3-unsaturated sialic acids for sialidase inhibition
49. Rapid access to uronic acid-based mimetics of Kdn2en from D-glucurono-6,3-lactone
50. Synthesis of novel sialylmimetics as biological probes
51. Introduction of C-sulfonate groups into disaccharide derivatives
52. A simple method for the preparation of thioglycosides of N-acetylneuraminic acid
53. Chemoselective deprotection of thioacetates with hydrazinium acetate